MENS
Income statement / Annual
Last year (2025), Jyong Biotech Ltd.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2025, Jyong Biotech Ltd.'s net income was -$4.67 M.
See Jyong Biotech Ltd.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$100.00 K
|
$120.00 K
|
$127.00 K
|
$122.00 K
|
$121.00 K
|
$0.00
|
| Gross Profit |
-$100.00 K
|
-$120.00 K
|
-$127.00 K
|
-$122.00 K
|
-$121.00 K
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$731.00 K
|
$927.00 K
|
$1.07 M
|
$1.29 M
|
$1.56 M
|
$1.52 M
|
| General & Administrative Expenses |
$0.00
|
$1.09 M
|
$1.68 M
|
$1.49 M
|
$791.00 K
|
$859.00 K
|
| Selling & Marketing Expenses |
$0.00
|
$44.00 K
|
$47.00 K
|
$47.00 K
|
$54.00 K
|
$72.00 K
|
| Selling, General & Administrative Expenses |
$1.78 M
|
$1.13 M
|
$1.73 M
|
$1.54 M
|
$845.00 K
|
$931.00 K
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$2.51 M
|
$2.06 M
|
$2.80 M
|
$2.83 M
|
$2.40 M
|
$2.45 M
|
| Cost And Expenses |
$2.61 M
|
$2.06 M
|
$2.80 M
|
$2.83 M
|
$2.40 M
|
$2.45 M
|
| Interest Income |
$610.00 K
|
$7.00 K
|
$56.00 K
|
$5.00 K
|
$6.00 K
|
$0.00
|
| Interest Expense |
$2.54 M
|
$1.04 M
|
$757.00 K
|
$765.00 K
|
$835.00 K
|
$832.00 K
|
| Depreciation & Amortization |
$100.00 K
|
$120.00 K
|
$127.00 K
|
$123.00 K
|
$122.00 K
|
$110.00 K
|
| EBITDA |
-$2.51 M |
-$1.86 M |
-$3.52 M |
-$5.74 M |
-$3.24 M |
-$2.34 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
-$2.06 M
|
-$963.00 K
|
-$1.60 M
|
-$3.80 M
|
-$1.79 M
|
$530.00 K
|
| Income Before Tax |
-$4.67 M
|
-$3.02 M
|
-$4.40 M
|
-$6.63 M
|
-$4.20 M
|
-$1.92 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Net Income |
-$4.67 M
|
-$3.02 M
|
-$4.40 M
|
-$6.63 M
|
-$4.20 M
|
-$1.92 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-0.064 |
-0.0397 |
-0.0579 |
-0.0872 |
-0.0552 |
-0.0268 |
| EPS Diluted |
-0.064 |
-0.0397 |
-0.0579 |
-0.0872 |
-0.0552 |
-0.0268 |
| Weighted Average Shares Out |
$73.01 M
|
$76.03 M
|
$76.03 M
|
$76.03 M
|
$76.03 M
|
$71.57 M
|
| Weighted Average Shares Out Diluted |
$73.01 M
|
$76.03 M
|
$76.03 M
|
$76.03 M
|
$76.03 M
|
$71.57 M
|
| Link |
|
|
|
|
|
|
